Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthma.

Houssen ME, Ragab A, Mesbah A, El-Samanoudy AZ, Othman G, Moustafa AF, Badria FA.

Clin Biochem. 2010 Jul;43(10-11):887-90. doi: 10.1016/j.clinbiochem.2010.04.061. Epub 2010 Apr 27.

PMID:
20430018
[PubMed - indexed for MEDLINE]
2.

Effects of supportive treatment such as antioxidant or leukotriene receptor antagonist drugs on inflammatory and respiratory parameters in asthma patients.

Tug T, Godekmerdan A, Sari N, Karatas F, Erdem ES.

Clin Pharmacol Ther. 2007 Mar;81(3):371-6.

PMID:
17339866
[PubMed - indexed for MEDLINE]
3.

Recent advances in the management of asthma using leukotriene modifiers.

Kemp JP.

Am J Respir Med. 2003;2(2):139-56. Review.

PMID:
14720013
[PubMed - indexed for MEDLINE]
4.

Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.

Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.

J Fam Pract. 2001 Jul;50(7):595-602.

PMID:
11485708
[PubMed - indexed for MEDLINE]
5.

Leukotriene modifier vs inhaled corticosteroid in mild-to-moderate asthma: clinical and anti-inflammatory effects.

Perng DW, Huang HY, Lee YC, Perng RP.

Chest. 2004 May;125(5):1693-9.

PMID:
15136378
[PubMed - indexed for MEDLINE]
6.

Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.

Schmitt-Grohé S, Zielen S.

Paediatr Drugs. 2005;7(6):353-63. Review.

PMID:
16356023
[PubMed - indexed for MEDLINE]
7.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
[PubMed - indexed for MEDLINE]
8.

The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.

Lanz MJ, Eisenlohr C, Llabre MM, Toledo Y, Lanz MA.

Ann Allergy Asthma Immunol. 2001 Oct;87(4):283-8.

PMID:
11686419
[PubMed - indexed for MEDLINE]
10.

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.

Wilson AM, Dempsey OJ, Sims EJ, Lipworth BJ.

Chest. 2001 Apr;119(4):1021-6.

PMID:
11296164
[PubMed - indexed for MEDLINE]
11.

Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist.

Nakasato H, Ohrui T, Sekizawa K, Matsui T, Yamaya M, Tamura G, Sasaki H.

J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):585-8.

PMID:
10482831
[PubMed - indexed for MEDLINE]
12.

Montelukast decreases plasma endothelin-1 and serum eosinophil cationic protein levels in paediatric atopic asthma.

Kopriva F, Janostáková A, Jarmila S, Zápalka M, Hajduch M.

Clin Drug Investig. 2006;26(6):351-6.

PMID:
17163269
[PubMed - indexed for MEDLINE]
13.

[Therapy of bronchial asthma. To fight inflammation].

[No authors listed]

MMW Fortschr Med. 2005 Feb 24;147(8):56. German. No abstract available.

PMID:
18441566
[PubMed - indexed for MEDLINE]
14.
15.

Compliance therapy with anti-inflammatory antiasthmatic drugs: inhaled corticosteroids and leukotriene receptor antagonists.

Riccioni G, Bucciarelli T, Mancini B, Di Ilio E, Palumbo G, D'Orazio N.

Clin Ter. 2007 Jul-Aug;158(4):363-70. Review.

PMID:
17953289
[PubMed - indexed for MEDLINE]
16.

The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma.

Salvi SS, Krishna MT, Sampson AP, Holgate ST.

Chest. 2001 May;119(5):1533-46. Review.

PMID:
11348965
[PubMed - indexed for MEDLINE]
18.

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.

Williams B, Noonan G, Reiss TF, Knorr B, Guerra J, White R, Matz J.

Clin Exp Allergy. 2001 Jun;31(6):845-54.

PMID:
11422148
[PubMed - indexed for MEDLINE]
19.

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.

Robinson DS, Campbell D, Barnes PJ.

Lancet. 2001 Jun 23;357(9273):2007-11.

PMID:
11438132
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk